Elizabeth E Reed Insider Trading Activity
Elizabeth E Reed has been net-selling over the last 12 months with 0 purchases and 16 sales across 1 company.
TVTX is the most-traded position with 16 trades. The largest single transaction was a sale of TVTX for $1.5M on Apr 14, 2026.
Performance Scorecard
Forward stock performance after each transaction by Elizabeth E Reed. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -5.0% | 31% | 16 |
| 90 days | — | -49.3% | 0% | 13 |
| 120 days | — | -61.0% | 0% | 8 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersTVTX · Travere Therapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Elizabeth E Reed bought and sold TVTX.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
May 6, 2026 | TVTX | Sell | 2,076 | $43.95 | $91K | −1.9% | Chief Legal Officer and GC | |
May 5, 2026 | TVTX | Sell | 2,174 | $46.65 | $101K | −2.0% | Chief Legal Officer and GC | |
May 4, 2026 | TVTX | Sell | 20,000 | $45.00 | $900K | −16.0% | Chief Legal Officer and GC | |
Apr 15, 2026 | TVTX | Sell | 5,226 | $41.62 | $218K | −4.7% | Chief Legal Officer and GC | |
Apr 15, 2026 | TVTX | Sell | 1,559 | $42.53 | $66K | −1.5% | Chief Legal Officer and GC | |
Apr 14, 2026 | TVTX | Sell | 7,215 | $41.93 | $303K | −6.1% | Chief Legal Officer and GC | |
Apr 14, 2026 | TVTX | Sell | 37,500 | $41.07 | $1.5M | −23.9% | Chief Legal Officer and GC | |
Apr 1, 2026 | TVTX | Sell | 10,000 | $30.00 | $300K | −8.7% | Chief Legal Officer and GC | |
Mar 16, 2026 | TVTX | Sell | 10,000 | $28.09 | $281K | −8.7% | Chief Legal Officer and GC | |
Feb 17, 2026 | TVTX | Sell | 5,679 | $27.50 | $156K | −4.9% | Chief Legal Officer and GC | |
Feb 17, 2026 | TVTX | Sell | 4,321 | $28.26 | $122K | −3.9% | Chief Legal Officer and GC | |
Feb 4, 2026 | TVTX | Sell | 2,485 | $32.07 | $80K | −2.3% | Chief Legal Officer and GC | |
Feb 4, 2026 | TVTX | Sell | 509 | $32.74 | $17K | −0.5% | Chief Legal Officer and GC | |
Feb 3, 2026 | TVTX | Sell | 7,175 | $32.12 | $230K | −6.2% | Chief Legal Officer and GC | |
Jan 20, 2026 | TVTX | Sell | 10,000 | $27.34 | $273K | −10.0% | Chief Legal Officer and GC | |
Sep 22, 2025 | TVTX | Sell | 10,000 | $25.00 | $250K | −10.0% | Chief Legal Officer and GC |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | 16 | $4.9M |
Other insiders at Travere Therapeutics, Inc.
7 other tracked filers at TVTX.